Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Dose Dexamethasone for the Prevention of Recurrent Wheeze in at Risk Children With First Episode LRTI: a Multi-country RCT in Two Low- and Middle-income Countries.

NCT07858773 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.

NCT NCT07858773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07858773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Dose Dexamethasone for the Prevention of Recurrent Wheeze in at Risk Children With First Episode LRTI: a Multi-country RCT in Two Low- and Middle-income Countries.
Lead sponsor
Norwegian University of Science and Technology
Phase
Phase 4
Overall status
Not yet recruiting
Start date
February 1, 2027
Completion date
January 30, 2029
Enrollment
486 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lower respiratory tract infection (lrti), recurrent wheezing